Zheng‐Gen Jin

3.5k citations
29 papers · 2.8k indexed · h-index 22
Topics
Angiogenesis and VEGF in Cancer (7 papers)Nitric Oxide and Endothelin Effects (3 papers)RNA regulation and disease (3 papers)

In The Last Decade

Zheng‐Gen Jin

29 papers receiving 2.7k citations

Peers

Zheng‐Gen Jin
Comparison fields: 5 of 115
  • Molecular Biology 1.8k
  • Immunology 590
  • Cell Biology 398
  • Physiology 378
  • Oncology 303
Replace Qingbo Xu with:
Qingbo Xu Austria
Motoi Ohba Japan
Narin Osman Australia
Almudena Porrás Spain
Diana Mechtcheriakova Austria
Chang-Hoon Woo South Korea
Deneys R. van der Westhuyzen United States
Philip M. Bauer United States
Jane McHowat United States
Timothy Soos United States
Zheng‐Gen Jin relative to Qingbo Xu Austria Qingbo Xu's profile →
Citations per field
00.5×3.3×
Qingbo Xu · 1×
Citations per year

Countries citing papers authored by Zheng‐Gen Jin

Since Specialization
Citations

This map shows the geographic impact of Zheng‐Gen Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng‐Gen Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng‐Gen Jin more than expected).

Fields of papers citing papers by Zheng‐Gen Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng‐Gen Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng‐Gen Jin. The network helps show where Zheng‐Gen Jin may publish in the future.

Co-authorship network of co-authors of Zheng‐Gen Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng‐Gen Jin. A scholar is included among the top collaborators of Zheng‐Gen Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng‐Gen Jin. Zheng‐Gen Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 51
2 17
3 136
4 8
5 7
6 71
7 46
8 16
9 178
10 54
11 139
12 72
13 153
14 55
15 104
16 21
17 65
18 313
19 174
20 208

About Zheng‐Gen Jin

Zheng‐Gen Jin is a scholar working on Biochemistry, Immunology and Molecular Biology, having authored 29 papers that have together received 2.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Nitric Oxide and Endothelin Effects (3 papers) and RNA regulation and disease (3 papers). The work is most often cited by research in Immunology (590 citations), Molecular Biology (1.8k citations) and Immunology and Allergy (151 citations). Zheng‐Gen Jin has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Bradford C. Berk, Chelsea Wong, Tatsuo Tanimoto, Andreea O. Lungu, Chang Hoon Ha, Duan‐Fang Liao, Bong Sook Jhun, Suowen Xu, Yan Chen and Matthew G. Melaragno. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026